David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Range Resources
RRC
$9.59B
| $49.5M | 0.06% |
4,406,471
+520,959
| +13% | +$5.65M |
|
377
Viasat
VSAT
$10.3B
| $49.3M | 0.06% |
636,009
+108,967
| +21% | +$7.58M |
|
378
PUT
Ford
F
$57.5B
| $49.1M | 0.06% |
5,590,000
-3,382,700
| -38% | -$29.1M |
|
379
Murphy Oil
MUR
$5.36B
| $49M | 0.06% |
1,673,556
+401,676
| +32% | +$11.4M |
|
|
TSS
380
DELISTED
Total System Services, Inc.
TSS
| $49M | 0.06% |
515,802
+222,536
| +76% | +$20.1M |
|
381
HDFC Bank
HDB
$121B
| $48.4M | 0.06% |
1,670,316
-1,953,808
| -54% | -$50.7M |
|
382
RTX Corp
RTX
$283B
| $48.4M | 0.06% |
596,199
-3,053,391
| -84% | -$232M |
|
383
CALL
Coca-Cola
KO
$392B
| $48.3M | 0.06% |
1,030,600
+606,800
| +143% | +$28.4M |
|
384
Yext
YEXT
$637M
| $48.2M | 0.06% |
2,204,759
+70,061
| +3% | +$1.27M |
|
385
Royal Bank of Canada
RY
$285B
| $48M | 0.06% |
635,667
+331,079
| +109% | +$25M |
|
386
PUT
Altria Group
MO
$110B
| $48M | 0.06% |
835,300
+465,900
| +126% | +$23.8M |
|
387
Middleby
MIDD
$5.22B
| $48M | 0.06% |
368,812
+201,912
| +121% | +$24.2M |
|
388
PUT
Mercado Libre
MELI
$97.5B
| $47.6M | 0.06% |
93,800
+30,900
| +49% | +$12.3M |
|
389
Molina Healthcare
MOH
$10.5B
| $47.5M | 0.06% |
334,942
-183,581
| -35% | -$24.8M |
|
390
Yum China
YUMC
$16.9B
| $47.3M | 0.06% |
1,054,082
+357,778
| +51% | +$14.1M |
|
391
Icon
ICLR
$13.3B
| $47.3M | 0.06% |
346,496
+326,542
| +1,636% | +$44.5M |
|
392
Canadian Pacific Kansas City
CP
$85B
| $47.3M | 0.06% |
1,147,125
-423,770
| -27% | -$17M |
|
|
STOR
393
DELISTED
STORE Capital Corporation
STOR
| $47.2M | 0.06% |
1,408,216
+435,107
| +45% | +$13.7M |
|
|
JWN
394
DELISTED
Nordstrom
JWN
| $47M | 0.06% |
1,058,028
+578,031
| +120% | +$26.4M |
|
395
Boeing
BA
$169B
| $46.9M | 0.06% |
123,083
-32,953
| -21% | -$12.7M |
|
396
PUT
Delta Air Lines
DAL
$54.2B
| $46.8M | 0.06% |
906,800
+322,800
| +55% | +$16M |
|
397
Zimmer Biomet
ZBH
$19.3B
| $46.1M | 0.06% |
372,173
-443,662
| -54% | -$50.4M |
|
|
AMED
398
DELISTED
Amedisys
AMED
| $45.7M | 0.06% |
370,538
+90,378
| +32% | +$11.3M |
|
399
Dick's Sporting Goods
DKS
$16.4B
| $45.5M | 0.06% |
1,236,521
+101,545
| +9% | +$3.62M |
|
400
Ionis Pharmaceuticals
IONS
$9.93B
| $45.2M | 0.06% |
557,191
+146,492
| +36% | +$9.45M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.